BIOMAT Database Logo BIOMAT Database Logo

4-Substituted anilino imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity. 2006

Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Dipartimento Farmaco Chimico Tossicologico, University of Sassari, Via Muroni 23/a, 07100 Sassari, Italy.

Fifteen imidazo[1,2-a] and [1,2,4]triazolo[4,3-a]quinoxalines were prepared. These compounds bear at position 4 various substituents related to the moieties present in classical and non-classical antifolic agents. And we evaluated in vitro antimicrobial, antiviral and antiproliferative activities. In particular, title compounds were evaluated in vitro against representative strains of Gram-positive and Gram-negative bacteria (S. aureus, Salmonella spp.), mycobacteria (M. fortuitum, M. smegmatis ATCC 19420 and M. tuberculosis ATCC 27294), yeast and moulds (C. albicans ATCC 10231 and A. fumigatus). Furthermore, their antiretroviral activity against HIV-1 was determined in MT-4 cells together with cytotoxicity. In these assays title compounds were tested for their capability to prevent MT-4 cell growth. Among the examined series, the compounds 5, 7 and 10 showed cytotoxicity against mock-infected MT-4 cells.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D011810 Quinoxalines Quinoxaline
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.
September 2003, Farmaco (Societa chimica italiana : 1989),
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Copper(II) chloride mediated synthesis and DNA photocleavage activity of 1-aryl/heteroaryl-4-substituted-1,2,4-triazolo[4,3-a]quinoxalines.
December 2011, European journal of medicinal chemistry,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
January 1988, Journal of medicinal chemistry,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
October 2006, Archiv der Pharmazie,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-Triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity.
December 1997, Archiv der Pharmazie,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
August 1997, Die Pharmazie,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
January 2007, Bioorganic & medicinal chemistry,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Synthesis and biological evaluation of 4-alkoxy-6,9-dichloro[1,2,4]triazolo[4,3-a]quinoxalines as inhibitors of TNF-α and IL-6.
August 2012, European journal of medicinal chemistry,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity.
March 2001, European journal of medicinal chemistry,
Paola Corona, and Gabriella Vitale, and Mario Loriga, and Giuseppe Paglietti, and Paolo La Colla, and Gabriella Collu, and Giuseppina Sanna, and Roberta Loddo
1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
May 1998, Archiv der Pharmazie,
Copied contents to your clipboard!